Analysis of bypass signaling in EGFR pathway and profiling of bypass genes for predicting response to anticancer EGFR tyrosine kinase inhibitors

Analysis of bypass signaling in EGFR pathway and profiling of bypass genes for predicting response to anticancer EGFR tyrosine kinase inhibitors

10.1039/c2mb25165e

Saved in:

Bibliographic Details
Main Authors:	Zhang, J., Jia, J., Zhu, F., Ma, X., Han, B., Wei, X., Tan, C., Jiang, Y., Chen, Y.
Other Authors:	PHARMACY
Format:	Article
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/105646
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations
by: Costa D.B., et al.
Published: (2018)

Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells
by: Boonyakorn Boonsri, et al.
Published: (2022)

Identification of vinyl sulfone derivatives as egfr tyrosine kinase inhibitor: In vitro and in silico studies
by: Thitinan Aiebchun, et al.
Published: (2022)

Sulfonylated Indeno[1,2-c]quinoline Derivatives as Potent EGFR Tyrosine Kinase Inhibitors
by: Hengphasatporn K.
Published: (2023)

Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinoma
by: Lee, S.-C., et al.
Published: (2012)

Simulation of the regulation of EGFR endocytosis and EGFR-ERK signaling by endophilin-mediated RhoA-EGFR crosstalk
by: Ung, C.Y., et al.
Published: (2014)

In-vitro studies of anti-egfr tyrosine kinase activity of thai nutraceutical plants
by: Suwanna Semsri, et al.
Published: (2020)

Case report: Management of Progressive Lung Cancer Patients after First-Line EGFR Tyrosine Kinase Inhibitor Therapy
by: Sahrun, -, et al.
Published: (2019)

EGFR kinase inhibitors and gastric acid suppressants in EGFR-mutant NSCLC: A retrospective database analysis of potential drug interaction
by: Kumarakulasinghe, N.B, et al.
Published: (2020)

Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors
by: Li, Y., et al.
Published: (2014)

Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance
by: Shimamura, T, et al.
Published: (2020)

Discovery of Anilino-1,4-naphthoquinones as Potent EGFR Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Comprehensive Molecular Modeling
by: Panupong Mahalapbutr, et al.
Published: (2022)

Discovery of Anilino-1,4-naphthoquinones as Potent EGFR Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Comprehensive Molecular Modeling
by: Mahalapbutr P.
Published: (2023)

Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma
by: Verma, Akash, et al.
Published: (2017)

Lazertinib Versus Gefitinib Tyrosine Kinase Inhibitors in Treatment-Naíve Patients With EGFR-Mutated Advanced NSCLC: Analysis of the Asian Subpopulation in LASER301
by: Reungwetwattana T.
Published: (2023)

Design and synthesis of receptor tyrosine kinase inhibitors for anticancer treatment
by: Chawannuch Mudjupa
Published: (2023)

Identification of tripeptides against tyrosine kinase domain of EGFR for lung cancer cell inhibition by in silico and in vitro studies
by: Duangnapa Kiriwan, et al.
Published: (2022)

Identification of tripeptides against tyrosine kinase domain of EGFR for lung cancer cell inhibition by in silico and in vitro studies
by: Kiriwan D.
Published: (2023)

Perbandingan Respons Terapi Penggunaan Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (Egfr-Tki) Generasi Pertama Pada Penderita Kanker Paru Karsinoma Bukan Sel Kecil (Kpkbsk) Dengan Mutasi Egfr Common Dan Uncommon
by: Rena Arusita Maranatha
Published: (2019)

Inhibitors of the tyrosine kinase signaling cascade for asthma
by: Wong, W.S.F.
Published: (2012)

EMT-Induced Stemness and Tumorigenicity Are Fueled by the EGFR/Ras Pathway
by: Voon, D.C.-C., et al.
Published: (2014)

Quinoxalinones as A Novel Inhibitor Scaffold for EGFR (L858R/T790M/C797S) Tyrosine Kinase: Molecular Docking, Biological Evaluations, and Computational Insights
by: Suriya U.
Published: (2023)

Impact of smoking and brain metastasis on outcomes of advanced EGFR mutation lung adenocarcinoma patients treated with first line epidermal growth factor receptor tyrosine kinase inhibitors
by: Jain A., et al.
Published: (2020)

CNS response to osimertinib versus standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated EGFR-mutated advanced non-small-cell lung cancer
by: Thanyanan Reungwetwattana, et al.
Published: (2019)

Simulation of crosstalk between small GTPase RhoA and EGFR-ERK signaling pathway via MEKK1
by: Li, H., et al.
Published: (2014)

Cell-penetrable nanobodies (transbodies) that inhibit the tyrosine kinase activity of EGFR leading to the impediment of human lung adenocarcinoma cell motility and survival
by: Lueacha Tabtimmai, et al.
Published: (2020)

Predicting Drug Combination Index and Simulating the Network-Regulation Dynamics by Mathematical Modeling of Drug-Targeted EGFR-ERK Signaling Pathway
by: Huang, L, et al.
Published: (2020)

Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer
by: Saifon W.
Published: (2023)

Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities
by: Lacouture, M.E., et al.
Published: (2014)

Endofin is a novel component in EGR/EGFR oncogenic signaling
by: TOY WEIYI
Published: (2011)

BMP Signaling in astrocytes downregulates EGFR to modulate survival and maturation
by: Scholze A.R., et al.
Published: (2019)

The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway
by: Jin, K., et al.
Published: (2014)

Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancer
by: Ali, A, et al.
Published: (2020)

Negative regulation of EGFR signalling by the human folliculin tumour suppressor protein
by: Laviolette L.A., et al.
Published: (2020)

ROLE OF INHIBITORS OF TYROSINE KINASE SIGNALING CASCADE IN AIRWAY SMOOTH MUSCLE FUNCTIONS
by: TSANG FAI
Published: (2019)

Bypassing industrial development
by: Batalla, Eric Vincent C.
Published: (2018)

Phosphorylation of Src by phosphoinositide 3-kinase regulates beta-adrenergic receptor-mediated EGFR transactivation
by: Lewis J. Watson, et al.
Published: (2018)

The function of TOM1-L1 in bridging EGFR signaling and endocytosis
by: LIU NINGSHENG
Published: (2010)

Hypoxia activated EGFR signaling induces epithelial to mesenchymal transition (EMT)
by: Misra, Ashish, et al.
Published: (2013)

Improving acetyl-CoA biosynthesis in Saccharomyces cerevisiae via the overexpression of pantothenate kinase and PDH bypass
by: Liu, Wenshan, et al.
Published: (2018)